PAA 3.13% 16.5¢ pharmaust limited

Ann: PharmAust Expands Lymphoma Canine Trial to the USA, page-55

  1. 2,565 Posts.
    lightbulb Created with Sketch. 1468
    "............I initially bought in to this Company for the canine cancer. In this regard I can see the light at the end of the tunnel.........."

    Great acknowledgement kpax. I'll go further than that and say I bought in to the story of the concept in arresting canine cancer with the potential upside of initial testing showing potential for human cancer. Not even a magic cure for all cancers but the prevention of progress for some enabling time for other treatments as well. A relatively conservative and straightforward story. Anything else falling under the heading of bonus and let all surprises be good. Frankly have not shifted my general position. Get that original story in to the market and the intrinsic value will take care of itself.
    Great weekend all !

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
16.5¢
Change
0.005(3.13%)
Mkt cap ! $80.22M
Open High Low Value Volume
16.5¢ 17.5¢ 16.5¢ $276.1K 1.636M

Buyers (Bids)

No. Vol. Price($)
4 379426 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.